Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new page revision, v3.6.4, was released replacing the previous v3.6.3. This update indicates a new version of the page, likely reflecting minor maintenance or formatting corrections rather than changes to study data.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe site platform version was updated from v3.6.2 to v3.6.3. This indicates a maintenance release for the portal and does not reflect changes to the study results or key details.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling a minor update to the public study record.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study page now shows that recruitment has closed for this trial. Additional help and navigation sections were added, including How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading.SummaryDifference0.4%

- Check59 days agoChange DetectedRevision tag updated to v3.5.5, replacing the previous v3.5.4. This indicates a minor page version update and does not change the study details or results shown on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedA new revision label v3.5.4 has been added, replacing the previous v3.5.3 label. This indicates the page has been updated to a newer revision of its content.SummaryDifference0.0%

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.